Biomarkers in malignant mesothelioma—an unfulfilled need or a waste of resources?

Robin Cornelissen, Joachim G.J.V. Aerts


The search for a molecular biomarker in malignant mesothelioma is as old as its first proven effective therapy (1,2). A definitive diagnostic biomarker could aid in establishing the diagnosis of malignant mesothelioma in patient.

Download Citation